WPG Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Buy
404
+87
+27% +$88.9K 0.28% 48
2026
Q1
$292K Sell
317
-42
-12% -$42.6K 0.21% 55
2025
Q4
$386K Sell
359
-1
-0.3% -$956 0.29% 49
2025
Q3
$275K Sell
360
-7
-2% -$5.21K 0.21% 60
2025
Q2
$286K Sell
367
-39
-10% -$30.3K 0.24% 55
2025
Q1
$335K Sell
406
-8
-2% -$6.66K 0.31% 47
2024
Q4
$320K Buy
+414
New +$343K 0.3% 56

Other funds holding LLY

WPG Advisers's LLY Position: Q2 2026 in Review

WPG Advisers increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $88.9K and bringing the position to 404 shares worth $485K. The position accounts for 0.28% of the portfolio, ranked #48.

WPG Advisers first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WPG Advisers held 404 shares of Eli Lilly worth $485K as of Q2 2026.
  • WPG Advisers bought 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
  • Eli Lilly made up 0.28% of WPG Advisers's portfolio in Q2 2026, its #48 holding.
  • WPG Advisers first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.